Biopharma Insights
Watson-Marlow
How is all single-use not created equal?
Ray Baldwin, business development manager, Watson-Marlow Fluid Technology Solutions (WMFTS) explains how all single-use is not created equal and how you can tell the difference.
7 Apr 2025
Emcor
Advanced analytics for operational excellence
In biopharma manufacturing, every second counts. Like in any industry, operational downtime breeds inefficiency. In the context of manufacturing, it can delay critical research and disrupt production and as a result.
12 Mar 2025
SEKISUI
Tech transfer for microbial therapeutic protein manufacturing
BioProduction by SEKISUI’s Kirsty Bellchambers and Aurore Laborie-Thompson share insights into what drug developers need to know about transferring their biologics processes to a CDMO partner.
3 Mar 2025
ra2 studio Shutterstock
Going global: are ambitious biotechs biting off more than they can chew?
Arriello’s Kate Coleman reviews the findings of new transatlantic research which charts biotechs’ evolving commercialisation strategies and regulatory preparations, and the realities they are experiencing.
18 Feb 2025
Gorodenkoff Shutterstock
Oncology dominates biopharma in business development and licensing
Anne Dhulesia, partner, Sean Dyson, partner, and Guy Stephens, manager, L.E.K. Consulting, discuss how oncology is the single largest therapeutic area for pharmaceutical sales worldwide.
28 Jan 2025
Valentin Valkov Shutterstock
2025 – The year ahead
It’s that time of year again when we take stock of the advances the biopharma industry has made and look ahead to the evolving client requirements that will shape 2025 and beyond. Subodh Deshmukh, CEO of Aragen Bioscience discusses.
24 Jan 2025
Deemerwha studio Shutterstock
Zymewire releases 2024 industry report
Zymewire has released its highly anticipated 2024 Biopharma Recap Report, offering data-driven insights into global biopharma funding, clinical trial activity, and biotech company formation over the prior year, based on data from biopharma companies.
31 Mar 2025
Chiesi Group
Chiesi acquires new manufacturing site in Nerviano
Chiesi Group, a biopharmaceutical company headquartered in Parma, Italy, has announced an investment in Nerviano (Milan, Italy), with the construction of a new facility for the production of its therapeutic solutions.
27 Mar 2025
APM Steam
APM Steam highlights HVAC insulation services
American Plant Maintenance (APM Steam) highlights its innovative HVAC insulation services, designed to provide significant energy savings and enhanced operational efficiency for biopharmaceutical and pharmaceutical facilities.
20 Mar 2025
Experience. Precision for Radiopharma Logistics. Marken
Winning the race against time with precision for critical Radiopharma shipments.
MM Group
The future of injectable pharma lies in topload packaging
In the fast-growing injectable pharmaceuticals market, which Markets & Markets projects will reach $1139.4 billion by 2029, one innovative approach stands out as particularly valuable: topload packaging design.
17 Apr 2025
Guardtech
Overcoming the challenges of constructing a new cleanroom in an old facility
Mark Wheeler, commercial director, Guardtech discusses how constructing new cleanroom facilities in older buildings can be a smart and cost-effective solution for applications looking to optimise their existing spaces.
16 Apr 2025
MAIN5
A new role for digital adoption platforms: ensuring compliant use of pharma GxP systems
Digital adoption platforms (a simple overlay to web/cloud-based systems) offer a practical solution, guiding users of each application, step by step, in correct, compliant data input. MAIN5’s Sabine Gölden assesses their potential.
15 Apr 2025
Broughton
Advancing sustainability in laboratory operations
Broughton, a analytical testing and consultancy firm, highlights its commitment to sustainability in laboratory operations by promoting environmentally responsible practices, ethical governance, and proactive maintenance strategies.
14 Apr 2025
Doro Guzenda Shutterstock
The role of automation in enhancing sterilisation processes
Ellie Gabel, Associate Editor for Revolutionized explains how cleaning and sterilisation are essential but often unoptimised processes within pharmaceutical facilities.
10 Apr 2025
Maks_lab Shutterstock
Q&A: Artiva allogeneic NK cell therapies for treating autoimmune disease
After Artiva Biotherapeutics announced the news of cryopreserved allogeneic NK cell therapies (AlloNK) for treating autoimmune disease, European Pharmaceutical Manufacturer spoke to Fred Aslan, president and CEO to learn more.
8 Apr 2025
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Experience. Precision for Radiopharma Logistics. Marken
Winning the race against time with precision for critical Radiopharma shipments.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00